本研究针对白内障合并散光患者，评估了AcrySof IQ Vivity Toric EDOF（扩展景深）人工晶状体（IOL）的临床疗效。研究通过前瞻性观察发现，该IOL在术后3个月可实现良好的中距离矫正视力（DCIVA为0.16 logMAR），且旋转稳定性优异（86%病例旋转≤5°），患者在中、远距离 ...

GENEVA--(BUSINESS WIRE)--Alcon (SIX/NYSE: ALC), the global leader in eye care dedicated to helping people see brilliantly, today revealed final data from its Vivity ® Registry Study, which monitored ...

This is a retrospective cohort study of 44 eyes of 33 patients. The eyes all had corneal astigmatism of 1 to 5 D, and between July 2006 and March 2007 received an AcrySof toric intraocular lens during ...

在白内障手术领域，新型人工晶状体（IOL）技术持续涌现，不断吸引着临床医生的关注。然而，新技术的普及往往伴随着审慎的观察与验证——医生们通常倾向于等待充足的疗效与安全性证据，才会将其纳入常规实践。本文基于2026年1月美国针对白内障手术医生的最新调研 ...

单片折叠式AcrySof人工晶体植入2年后，内皮细胞密度处于预期范围内。 斯德哥尔摩讯—来自一项欧洲多中心研究的2年数据表明，爱尔康(Alcon)的房角支撑型有晶体眼IOL AcrySof在高度近视矫正中，似乎安全有效。 尤其，似乎不需要担心内皮细胞密度的问题，因为 ...

Please provide your email address to receive an email when new articles are posted on . A prospective comparative case series of 50 patients implanted bilaterally ...

PanOptix, the first and only advanced trifocal lens for U.S. patients undergoing cataract surgery, will be showcased in educational events and clinical data presentations First-ever analyses on IOLs ...

PanOptix delivers an exceptional combination of near, intermediate and distance vision and substantially reduces the need for glasses 1,2 More than ninety-nine percent of PanOptix patients in the FDA ...

PanOptix is already one of the leading presbyopia-correcting IOLs in more than 70 countries. It is designed for today’s active lifestyles, from viewing mobile devices and computer screens to ...

Here is the current list (as of Feb. 9, 2011) of posterior chamber (P-C) and anterior chamber (A-C) intraocular lenses recognized by CMS. – Crystalens, manufactured by Eyeonics (now Bausch & Lomb). – ...

TORONTO, Nov. 17, 2020 /CNW/ - Alcon, the global leader in eye care, is pleased to announce the Canadian launch of AcrySof ® IQ Vivity ®, a first-of-its-kind, surgical lens designed to help cataract ...